- Home
- PTGX vs USA Comparison
PTGX vs USA Comparison
Compare PTGX & USA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PTGX | USA |
|---|---|---|
| Founded | 2006 | 1986 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance Companies |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.4B | 1.8B |
| IPO Year | 2016 | N/A |
Fundamental Metrics
Financial Performance| Metric | PTGX | USA |
|---|---|---|
| Price | $94.47 | $6.18 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 9 | 0 |
| Target Price | ★ $88.33 | N/A |
| AVG Volume (30 Days) | ★ 953.6K | 880.5K |
| Earning Date | 11-06-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 9.66% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.72 | N/A |
| Revenue | ★ $209,217,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $296.47 | N/A |
| P/E Ratio | $132.39 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $33.70 | $5.62 |
| 52 Week High | $95.39 | $7.09 |
Technical Indicators
Market Signals| Indicator | PTGX | USA |
|---|---|---|
| Relative Strength Index (RSI) | 70.99 | 52.22 |
| Support Level | $88.30 | $5.80 |
| Resistance Level | $92.80 | $6.20 |
| Average True Range (ATR) | 2.82 | 0.06 |
| MACD | 0.19 | 0.02 |
| Stochastic Oscillator | 94.19 | 83.81 |
Price Performance
Historical ComparisonAbout PTGX Protagonist Therapeutics Inc.
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.
About USA Liberty All-Star Equity Fund
Liberty All Star Equity Fund is a multi-managed fund. Its objective is to provide a high level of current income and long-term capital appreciation through investing principally in a diversified portfolio of equity securities. The fund invests in various sectors, including financials, information technology, healthcare, consumer discretionary, consumer staples, industrials, energy, materials, real estate, utilities, telecommunication, and other services.